Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
161 studies found for:    Encephalitis
Show Display Options
Rank Status Study
21 Completed Safety and Efficacy Study of Intravenous Immunoglobulin to Treat Japanese Encephalitis
Condition: Japanese Encephalitis
Intervention: Drug: Intravenous immunoglobulin [ImmunoRel™ (batch 20081217)]
22 Completed An Extension Study to Determine the Persistence of Tick-borne Encephalitis (TBE)-Specific Antibody Responses Among Children and Adolescents Previously Immunized Against TBE
Condition: Tick Borne Encephalitis (TBE)
Intervention: Other: Serology blood draw
23 Completed A Pilot Study of the Use of Rituximab in the Treatment of Chronic Focal Encephalitis
Conditions: Chronic Focal Encephalitis;   Rasmussen's Encephalitis
Intervention: Drug: Rituximab
24 Unknown  Treatment of Japanese Encephalitis
Condition: Japanese Encephalitis
Intervention: Drug: Ribavirin
25 Withdrawn Safety, Tolerability and Immunogenicity of the Venezuelan Equine Encephalitis (VEE) Attenuated Live-Virus Vaccine
Condition: Venezuelan Equine Encephalitis
Intervention: Biological: VEE 3526
26 Completed
Has Results
Longterm Immunogenicity of the Japanese Encephalitis Vaccine IC51
Condition: Japanese Encephalitis
Intervention: Biological: Japanese Encephalitis purified inactivated vaccine
27 Completed
Has Results
Rapid Immunization Study of the Japanese Encephalitis Vaccine IC51
Condition: Japanese Encephalitis
Intervention: Biological: IC51
28 Completed
Has Results
Safety and Tolerability of the Japanese Encephalitis Vaccine IC51
Condition: Japanese Encephalitis
Interventions: Biological: Japanese Encephalitis purified inactivated vaccine (IC51);   Biological: Placebo
29 Completed
Has Results
Comparison of Three Batches of the Japanese Encephalitis Vaccine IC51
Condition: Japanese Encephalitis
Intervention: Biological: IC51
30 Completed
Has Results
Immunogenicity Study of the Japanese Encephalitis Vaccine IC51
Condition: Japanese Encephalitis
Interventions: Biological: IC51;   Biological: JE-VAX
31 Completed
Has Results
Long Term Persistence and Effect of a Booster Dose of the Japanese Encephalitis Vaccine IC51
Condition: Japanese Encephalitis
Intervention: Biological: IC51
32 Completed
Has Results
Effect of a Booster Dose of the Japanese Encephalitis Vaccine IC51
Condition: Japanese Encephalitis
Intervention: Biological: IC51
33 Completed Live Attenuated Japanese Encephalitis (JE) Vaccine Coadministered With Measles Vaccine in Infants 9 Months of Age
Condition: Japanese Encephalitis
Intervention: Biological: Japanese encephalitis live attenuated SA 14-14-2 vaccine
34 Active, not recruiting Tick-Borne Encephalitis (TBE) Seropersistence After First Booster in Children, Adolescents and Young Adults (Follow-Up to Study 700401)
Condition: Encephalitis, Tick-Borne
Intervention: Biological: FSME-IMMUN 0.25 mL Junior (1.2 µg TBE antigen/0.25 mL) or FSME-IMMUN 0.5 mL (2.4µg TBE antigen/0.5 mL)
35 Completed
Has Results
Comparison of Three Commercial Batches of the Japanese Encephalitis Vaccine IC51
Condition: Japanese Encephalitis
Intervention: Biological: Japanese Encephalitis purified inactivated vaccine
36 Not yet recruiting Antibody Response of a Boosted Japanese Encephalitis Chimeric Virus Vaccine (JE-CV) in Children
Condition: Japanese Encephalitis
Intervention: Biological: Japanese encephalitis chimeric vaccine (JECV)
37 Completed Boosterability of Live Attenuated Japanese Encephalitis (JE) Vaccine in Children Who Have Previously Received Inactivated JE Vaccine
Condition: Japanese Encephalitis
Intervention: Biological: Japanese encephalitis live attenuated SA 14-14-2 vaccine
38 Completed
Has Results
A Safety and Efficacy Study of Two Japanese Encephalitis Vaccines ChimeriVax™-JE and JE-VAX
Condition: Japanese Encephalitis
Interventions: Biological: ChimeriVax™-JE;   Biological: JE-VAX®
39 Active, not recruiting Study of a DNA-based Venezuelan Equine Encephalitis Virus DNA Vaccine Administered by Electroporation in Healthy Volunteers
Condition: Venezuelan Equine Encephalitis Virus Infection
Interventions: Biological: Venezuelan Equine Encephalitis Virus DNA Vaccine Candidate;   Other: 0.9% saline placebo
40 Completed Safety and Immunogenicity of 2 Different Vaccination Schedules of Rabies and Japanese Encephalitis Vaccines in Healthy Adult Subjects
Conditions: Rabies;   Japanese Encephalitis
Interventions: Biological: Rabies;   Biological: Japanese Encephalitis

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Indicates status has not been verified in more than two years